MorningRX: August 18, 2023
Drug Topics
AUGUST 18, 2023
NIH establishes research centers for maternal health, FDA grants priority review for IgA nephropathy treatment, and the CDC begins tracking a new COVID-19 variant.
Fri.Aug 18, 2023
247 
Behind Flagship Pioneering’s triumphs and tribulations
PharmaVoice
AUGUST 18, 2023
With Flagship and Pfizer’s newly announced partnership to find the next big blockbuster, we’re examining some of the VC fund’s biggest successes and failures to date.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
What You Need to Know About the Drug Supply Chain Security Act Before November’s Deadline
Drug Topics
AUGUST 18, 2023
A Q&A with Matt Sample, senior vice president of manufacturer and replenishment operations at AmerisourceBergen.
Precision Medicine Has Broadened the Application of Gene Therapy Testing, Further Specialization May Be Needed to Interpret Results
Pharmacy Times
AUGUST 18, 2023
Opportunities for an additional specialization in molecular pathology may be helpful to train professionals in the real-time interpretation of gene therapy test results.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Podcast: Is The Pharmacy World Prepared For DSCSA?
Drug Topics
AUGUST 18, 2023
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
How Pharmacists Can Help Protect Patients’ Skin From Sunburn, Skin Cancer
Pharmacy Times
AUGUST 18, 2023
Pharmacists can offer valuable information about sunburn, sunscreen, and skin cancer screening and provide OTC recommendations on sunburn treatment and prevention.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Use of First-Line Treatment for Insomnia Low Among Adults With Mental Health Conditions
Pharmacy Times
AUGUST 18, 2023
Although the rate of people with probable insomnia who discussed their sleep habits with a physician was relatively high, the number of people who went on to seek actual treatment was low.
Turmeric for Your Thyroid and Hashimoto’s
The Thyroid Pharmacist
AUGUST 18, 2023
I love the concept of using food as medicine — or as I like to call it, food pharmacology. I became a pharmacist because I was interested in the effects that different substances have on human physiology. Medications are an obvious example of how tiny substances can produce a tremendous change in the human body, but what’s even more intriguing to me is the profound effect that foods and natural substances can have on the body.
Understand the Underlying Causes, Challenges of Treating Obesity
Pharmacy Times
AUGUST 18, 2023
Guidelines from the American Academy of Pediatrics recommend treating obesity as a chronic illness.
STAT+: An innovative eye stem cell transplant could help restore vision in people with chemical injuries
STAT
AUGUST 18, 2023
The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Case Study: Positive HIV-1 Status Should Not Preclude Heart Transplant
Pharmacy Times
AUGUST 18, 2023
Previous studies have shown promising results with liver or kidney transplants in patients with HIV, but there was a lack of literature regarding heart transplants specifically.
Viome Life Sciences banks $86.5M round, partners with CVS to sell at-home diagnostic tests
Fierce Healthcare
AUGUST 18, 2023
At-home diagnostics startup Viome Life Sciences snagged $86.5 million in an oversubscribed series C funding round and will roll out its gut microbiome testing kit into 200 CVS stores. | At-home diagnostics startup Viome Life Sciences snagged $86.5 million in an oversubscribed series C funding round and will roll out its gut microbiome testing kit into 200 CVS stores.
New Method Enables Assessment of Immunological Reaction to mRNA SARS-CoV-2 Vaccine
Pharmacy Times
AUGUST 18, 2023
The approach allows investigators to assess post-vaccine response in immunocompromised patients who have received antibody prophylaxis.
Why so few get screened for lung cancer, the deadliest cancer in the U.S.
STAT
AUGUST 18, 2023
It was Thanksgiving 2021, and Michael Young was at Target buying a turkey baster. “I’m in the parking lot, and my chest starts to feel like somebody’s sitting on me,” Young recounted. But he didn’t think too much of it and waited until February to tell the doctor about these on-and-off chest pains. “8:30 a.m.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Data Show Durable Efficacy With Repotrectinib for Locally Advanced or Metastatic ROS1-Positive NSCLC
Pharmacy Times
AUGUST 18, 2023
Based on results from a trial of repotrectinib in patients with ROS1-positive locally advanced or metastatic non-small cell lung cancer, the FDA accepted the New Drug Application and set a Prescription Drug User Fee Act goal date of November 27, 2023.
List prices for Ozempic, Wegovy far higher in the US than in peer nations: KFF
Fierce Healthcare
AUGUST 18, 2023
It's not a secret that Americans pay far more than people living in other countries for drugs, and those data hold for trendy weight loss and diabetes treatments as demand for these therapies grows | It's not a secret that Americans pay far more than people living in other countries for drugs, and those data hold for trendy weight loss and diabetes treatments like Ozempic and Wegovy.
Ex-UK deputy medical officer Van-Tam takes role at Moderna
pharmaphorum
AUGUST 18, 2023
Ex-UK deputy medical officer Van-Tam takes role at Moderna Phil.
Opinion: Medicine robs physicians of their fertility. Here’s how to fix it
STAT
AUGUST 18, 2023
“T he Retrievals,” a disturbing podcast from Serial and the New York Times released this summer, painstakingly tells the stories of women who sought fertility treatments at the Yale Fertility Center in 2020. Over the course of five months, women underwent egg retrievals without any pain medication. Although this procedure is typically done under heavy sedation, a nurse at the clinic had replaced fentanyl with saline.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Improving treatment for high-risk cataract surgery
pharmaphorum
AUGUST 18, 2023
Improving treatment for high-risk cataract surgery Mike.
ProMED sees offers of support, but its future remains unclear
STAT
AUGUST 18, 2023
With its future in doubt, ProMED, the financially strapped infectious diseases surveillance network, has seen waves of support pour in in recent weeks, with universities and other funders seeking to rescue it, according to the president of the committee that oversees it. Both the International Society for Infectious Diseases, which has hosted ProMED since 1999, and its moderators, many of whom went on strike earlier this month to protest plans to put the service behind a paywall, have been in di
Health Innovators – Dr Jack Hoppin and Dr John Babich (follow-up)
pharmaphorum
AUGUST 18, 2023
Health Innovators – Dr Jack Hoppin and Dr John Babich (follow-up) Mike.
Having celiac disease and a thyroid condition sent her on a quest to become an empathetic doctor
STAT
AUGUST 18, 2023
A third-year med school student, Brianna Celix doesn’t get a lot of free time. Even with the one afternoon off she gets each week at the Medical College of Wisconsin in Milwaukee, Celix is being challenged to take care of herself. Her cat, Frankie, dense as a log, offers plenty of cuddles. But managing two autoimmune conditions requires more than animal affection.
AbbVie achieves win for migraine prevention drug Aquipta in Europe
Pharmaceutical Technology
AUGUST 18, 2023
The decision brings the first daily oral migraine prophylactic to Europe, with plans to rollout the treatment as soon as possible.
STAT+: Pharmalittle: Weight loss drugs cost much more in the U.S.; PBMs win a key victory over an Oklahoma law
STAT
AUGUST 18, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to catch up on our reading, promenade with the official mascots, and have a listening party with Mrs. Pharmalot. The rotation will likely include this , this , this , and this.
EMA accepts for review Iveric Bio’s MAA for geographic atrophy therapy
Pharmaceutical Technology
AUGUST 18, 2023
Astellas Pharma has announced that EMA has accepted the MAA from its subsidiary Iveric Bio for the review of ACP to treat GA.
Wakefern expands engagement with Simbe to more ShopRite stores
Drug Store News
AUGUST 18, 2023
Following a pilot in 20 stores, Wakfern is expanding its use of Simbe's business intelligence solution to additional ShopRite stores.
Bruker to buy cell biology company PhenomeX for $108m
Pharmaceutical Technology
AUGUST 18, 2023
Bruker has entered into a definitive agreement to acquire functional cell biology company PhenomeX for a total equity value of $108m.
CHMP to review MAA for geographic atrophy treatment
European Pharmaceutical Review
AUGUST 18, 2023
The European Medicines Agency (EMA) has accepted for regulatory review the marketing authorisation application (MAA) for avacincaptad pegol (ACP) to treat geographic atrophy (GA). “This acceptance of our EU Marketing Authorisation Application is a key milestone in our global effort to help patients living with GA, a leading cause of blindness worldwide.
Biogen kicks off 1,000 layoffs as part of CEO Viehbacher’s ‘complete redesign’
Fierce Pharma
AUGUST 18, 2023
It was only last spring that Biogen started a | It was only last spring that Biogen started layoffs that eventually shrank the company’s headcount by nearly 900 people last year. Now, a fresh round of job cuts targeting 1,000 positions has kicked off at the struggling drugmaker. At the same time, Biogen is spending $7.3 billion to buy rare disease specialist Reata Pharmaceuticals.
STAT+: Up and down the ladder: The latest comings and goings
STAT
AUGUST 18, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Please note that our regular feature — in which we spotlight someone — will return later this month.
Placer.ai takes stock of how superstores are faring amid economic headwinds
Drug Store News
AUGUST 18, 2023
Placer.ai analyzed traffic data for Walmart, Target, Costco Wholesale, BJ’s Wholesale Club and Sam’s Club to see how the sector is faring as consumer sentiment improves.
Boehringer Ingelheim advances weight loss drug to Phase III trials
Pharmaceutical Technology
AUGUST 18, 2023
Depending on Phase III results, survodutide could soon enter the weight loss market, which is expected to reach $37.1bn by 2031.
Labor marketplace company CareRev launches new tool to build flexible staffing pools within health systems
Fierce Healthcare
AUGUST 18, 2023
Workforce challenges continue to be front of mind for health system executives as the industry contends with ongoing staff shortages, nurse retention issues and clinician burnout. | CareRev has created what it calls the largest on-demand workforce and a technology platform to build and manage it. The company believes it can leverage this technical know-how to help health systems more effectively manage their own flexible staffing resources.
Let's personalize your content